Multimodality therapy means using more than one type of cancer treatment as part of a coordinated plan. It commonly combines local treatments (like surgery or radiation) with systemic treatments (like chemotherapy or immunotherapy). It is used across many cancers to improve tumor control and address cancer cells in different locations. It is planned and delivered by a multidisciplinary oncology team.

Local therapy is cancer treatment directed at a specific tumor or a defined body area. It aims to remove, destroy, or control cancer where it is located rather than treating the whole body. It is commonly used in solid tumors and in selected situations for symptom relief. It may be used alone or combined with systemic therapy (treatments that circulate throughout the body).

Systemic therapy is cancer treatment that travels through the bloodstream to reach cells throughout the body. It is commonly delivered as medication, such as pills, injections, or intravenous (IV) infusions. Oncology teams use it to treat cancer that has spread, could spread, or cannot be fully treated with local methods alone. It is used across many cancer types, including solid tumors and blood cancers.

Anticancer therapy is any treatment intended to control, shrink, remove, or slow the growth of cancer. It includes local treatments (like surgery or radiation) and systemic treatments (like chemotherapy or immunotherapy). It is commonly used in hospitals, cancer centers, and outpatient oncology clinics. It may be given with curative intent, to reduce recurrence risk, or to relieve symptoms.

Consent for chemotherapy is the process of giving informed permission to receive chemotherapy treatment. It means the care team explains the plan, and the patient (or legal decision-maker) agrees based on understanding and choice. It is commonly used in outpatient infusion centers, inpatient oncology units, and hematology-oncology clinics. It is also used when chemotherapy plans change or new risks and alternatives need to be discussed.

Chemo education is structured teaching that helps patients and caregivers understand chemotherapy and how it is delivered. It explains what to expect before, during, and after treatment, including side effects and monitoring. It is commonly provided in medical oncology clinics, infusion centers, and hospital oncology units.

A Treatment plan is a structured roadmap for cancer care. It summarizes what the care team is treating, what the goals are, and what steps come next. It is commonly used in oncology clinics, hospitals, and multidisciplinary cancer programs. It is also used to coordinate care across surgery, medical oncology, radiation oncology, and supportive services.

An Order set is a predefined group of medical orders used together for a specific clinical situation. It is commonly built into electronic health records (EHRs) and hospital ordering systems. Oncology teams use it to standardize common cancer-care workflows such as chemotherapy support, infection evaluation, or symptom control. It helps clinicians place the right labs, medications, imaging, and consults more consistently.

Pathway is a structured route or plan that describes how cancer care is delivered from first concern to follow-up. It can describe a clinical process (a “care Pathway”) or a biologic process (a “molecular Pathway”) involved in cancer. In oncology clinics, Pathway most often means a standardized care plan that helps teams coordinate diagnosis, treatment, and support. It is commonly used in hospitals, cancer centers, screening programs, and multidisciplinary tumor boards.

A Protocol is a written, step-by-step plan for delivering care in a consistent way. In oncology, a Protocol can guide diagnosis, staging, treatment, symptom control, and follow-up. Clinicians use Protocol documents in clinics, hospitals, infusion centers, and radiation departments. Researchers also use a Protocol to run clinical trials safely and consistently.